BILLERICA, Mass.--(BUSINESS WIRE)--Feb. 22, 2006--Millipore Corporation (NYSE:MIL), a leading provider of products and services that improve productivity in the laboratory and in biopharmaceutical manufacturing, today announced it has been added to KLD's Domini 400 Social Index. The Index consists of 400 U.S. companies and is used by professional investors to identify organizations that exhibit positive social and environmental records. Millipore was chosen for inclusion in the Index based on a variety of factors, including its leadership in community relations, corporate governance, and product quality and safety.

Millipore has a long history of demonstrating leadership in corporate responsibility and community service and was named one of America's Top 100 Corporate Citizens by Business Ethics Magazine in 2005. In 1985, the Company created the Millipore Foundation, which issues grants to not-for-profit organizations that support educational, social service, cultural, and healthcare related initiatives. Since its inception, the Millipore Foundation has invested approximately $21 million in local communities and programs that benefit underprivileged children, the elderly, local hospitals, and health care agencies.

Millipore has also been recognized for its environmental conservation efforts receiving a 2005 Environmental Merit Award for its water conservation program from the Environmental Protection Agency. Additionally, the Company was recently awarded an "Excellence in Pollution Prevention Award" by the State of New Hampshire and received the governor's award for pollution prevention three times since 1999.

"By being a leader in corporate responsibility, our customers, partners, employees and shareholders can feel confident about our values as an organization," said Martin Madaus, Chairman, President and CEO of Millipore. "We recognize that leadership goes beyond just generating impressive financial results and we understand that for Millipore to be successful over the long-term we must also strive to have an impact on the local environments and communities where we operate. We are proud of our inclusion in the Domini 400 Social Index and we are pleased to be associated with other high-profile companies that are committed to corporate and social responsibility."

As of January 2006, more than $2 billion in assets have been invested in funds based on the Index. KLD Indexes is a division of KLD Research & Analytics, an independent investment research firm providing investment management tools used by professionals to serve clients with investment strategies based on corporate, social and environmental performance. Launched in 1990, the Domini 400 Social Index is the first benchmark for equity portfolios subject to social and environmental screens. Its 15-year return of approximately 492 percent was nearly 66 percentage points higher than the S&P 500 index during the same period.

About Millipore

Millipore is a leading bioprocess and bioscience products and services company, organized into two divisions. The Bioprocess division offers solutions that optimize development and manufacturing of biologics. The Bioscience division provides high performance products and application insights that improve laboratory productivity. Millipore has a deep understanding of its customers' research and manufacturing process needs, and offers reliable and innovative tools, technologies and services. The Company employs approximately 4,800 people worldwide and posted revenues of $991 million in 2005.

For additional information on Millipore Corporation, please visit its website at: www.millipore.com.

Forward Looking Statements:

The matters discussed herein, as well as in future oral and written statements by management of Millipore Corporation that are forward-looking statements, are based on current management expectations that involve substantial risks and uncertainties which could cause actual results to differ materially from the results expressed in, or implied by, these forward-looking statements.

Potential risks and uncertainties that could affect Millipore's future operating results include, without limitation, foreign exchange rates; regulatory delay in the approval of new therapeutics and their ultimate commercial success; competitive factors such as new membrane technology; lack of availability of raw materials or component products on a timely basis; inventory risks due to shifts in market demand; change in product mix; conditions in the economy in general and in the bioscience and bioprocess markets in particular; potential environmental liabilities; the inability to utilize technology in current or planned products due to overriding rights by third parties; the inability to successfully integrate acquired businesses; the inability to realize the expected benefits of development, marketing and other alliances; difficulties inherent in transferring or outsourcing of manufacturing operations; difficulties inherent in research and development activities; and the risk factors listed from time to time in Millipore's filings with the SEC.

Copyright Business Wire 2006

Millipore Corporation

Millipore Corporation

More from Millipore Corporation